Human Medicines

This area of the website provides information relating to the regulation of human medicines, including access to product information, pharmacovigilance and the directory of relevant agencies.
HUMAN MEDICINES | RECENTLY PUBLISHED
Member: Sigridur KristinsdottirAlternate: Bryndís Ragnarsdóttir
Icelandic…
modified 20/11/2026
ENANTONE LP and assiciated names (Leuprorelin acetate)End of procedure:…
added 19/11/2026
Leucrin PDS Depot (Leuprorelin acetate)End of procedure: 08/02/2025Date of…
modified 19/11/2026
Added in November 2026
19 November
NEW - Art. 45 Public PdAR TetracosactideNEW…
modified 19/11/2026
Riamet (artemether / lumefantrine)UK/W/0096/pdWS/001End of procedure:…
modified 19/11/2026
TetracosactideEnd of procedure: 05/10/2026Date of publication: 19/11/2026
added 19/11/2026
MSs Recommendations on Extension Applications in Mutual Recognition and…
modified 19/11/2026
Information on nitrosamines for marketing authorisation holders
modified 19/11/2026
For additional specific information related to nationally authorised products…
modified 19/11/2026
CMDH PRESS RELEASES 2026
modified 18/11/2026
